Autoimmune Encephalitis and Paraneoplastic Syndrome: Current Knowledge and Updates provides an overview of the immune-driven disorders of the nervous system, particularly autoimmune encephalitis. By integrating case studies, flow charts, and clinical examples throughout, the book helps users navigate the complexities of autoimmune encephalitis. Sections also address demographic traits, tumor correlations, and outcomes, equipping readers with essential knowledge for diagnosis and management. With a strong focus on classifying these disorders, defining their pathogenesis and pathophysiology, and examining recent treatment guidelines, this book serves as a comprehensive guide for clinicians, neurologists, and researchers in neuroimmunology.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Definition, classification, and epidemiology of autoimmune encephalitis2. General approach to diagnosis and work up for autoimmune encephalitis
3. Pathogenesis, pathophysiology and disease mechanism of neuronal antibody mediated encephalitis
4. Classification of Autoimmune Encephalitis
5. Recent Treatment Guidelines and approach toward autoimmune encephalitis
6. Newer autoimmune syndromes and updates on clinical trials
7. Neuroimaging and biomarkers in autoimmune CNS disorders
Authors
Shitiz Sriwastava Assistant Professor, Department of Neurology with the Division of Multiple Sclerosis and Neuroimmunology, The University of Texas Health Science Center at Houston, USA.Dr. Shitiz K. Sriwastava, MD, is an Assistant Professor in the Department of Neurology with the Division of Multiple Sclerosis and Neuroimmunology at the University of Texas Health Science Center - Houston (UTHealth). He is a board-certified neurologist specialized in multiple sclerosis (MS). During his fellowship training and residency at Wayne State, he performed clinical research on MS and related autoimmune disorders of the central nervous system. He has had many years of experience in MS related clinical trials as a fellow or co-investigator. Dr. Sriwastava has a keen interest in identifying prognostic markers to predict the initiation and progression of MS especially early neurogenerative changes and also DTI studies in MS. He is currently a member of the American Academy of Neurology. His clinical, basic and translational studies in neuroimmunologic diseases have resulted in 50 peer reviewed papers and reports, published abstracts from national and international meetings.
